Frissora Mark P's Form 4 filing
Bioadaptives, Inc. (BDPT) · filed May 5, 2025
- Accession no.
- 0001193805-25-000608
- Filed
- May 5, 2025
- Trade date
- Feb 15-Apr 15, 2025
- Filing delay
- 79 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 5 derivative transactions. It was filed 79 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Frissora Mark PCIK 0001239786 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
This filing has no transactions of this kind.
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 15, 2025 | Common Stock | AGrant or awardAcquired | +45,500 | $11.00F2 | +$5,005 | 4,092 | Direct | |
| Mar 15, 2025 | Common Stock | AGrant or awardAcquired | +47,900 | $10.45F3 | +$5,005.55 | 4,571 | Direct | |
| Apr 9, 2025 | Common Stock | PPurchaseAcquired | +3,986,800 | $7.52F4 | +$299,807.36 | 44,439 | Direct | |
| Apr 9, 2025 | Common Stock | PPurchaseAcquired | +500,000 | –F5 | – | 1 | Direct | |
| Apr 15, 2025 | Common Stock | AGrant or awardAcquired | +50,100 | $9.99F6 | +$5,004.99 | 44,940 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents shares of Series D Convertible Preferred Stock issued as compensation for board services based on a closing price per share of the Issuer's common stock of $0.1100 on February 14, 2025, times 100.
Referenced by the price of 1 transaction in Table II.
- F3
Represents shares of Series D Convertible Preferred Stock issued as compensation for board services based on a closing price per share of the Issuer's common stock of $0.1045 on March 14, 2025, times 100.
Referenced by the price of 1 transaction in Table II.
- F4
The price per share is based on the average closing price of the Issuer's common stock for the five days prior to the transaction date, less a 20% discount, times 100.
Referenced by the price of 1 transaction in Table II.
- F5
The option to purchase 500,000 shares of the Issuer's common stock was granted to the Reporting Person in connection with the Preferred D Stock Purchase Agreement, dated April 9, 2025, between the Issuer and the Reporting Person. No additional consideration was paid to the Issuer in exchange for such option beyond the consideration paid in exchange for the Series D Convertible Preferred Stock.
Referenced by the price of 1 transaction in Table II.
- F6
Represents shares of Series D Convertible Preferred Stock issued as compensation for board services based on a closing price per share of the Issuer's common stock of $0.0999 on April 15, 2025, times 100.
Referenced by the price of 1 transaction in Table II.